Evidence map›Paper›PMID 36071463›Full record

ArticleTrials2022

Digital psychosocial intervention for depression among older adults in socioeconomically deprived areas in Brazil (PRODIGITAL-D): protocol for an individually randomised controlled trial.

Carina Akemi Nakamura, Marcia Scazufca, Felipe Azevedo Moretti, Thiago Vinicius Nadaleto Didone, Mariana Mendes de Sá Martins, Luara Aragoni Pereira, Caio Hudson Queiroz de Souza, Gabriel Macias de Oliveira, Marcelo Oliveira da Costa, Marcelo Machado and 8 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Nanoencapsulation ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Carina Akemi Nakamura *Departamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Marcia Scazufca *Departamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil. scazufca@usp.br.
Felipe Azevedo MorettiDepartamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Thiago Vinicius Nadaleto DidoneDepartamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Mariana Mendes de Sá MartinsDepartamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Luara Aragoni PereiraInstituto de Psiquiatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Caio Hudson Queiroz de SouzaDepartamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Gabriel Macias de OliveiraDepartamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Marcelo Oliveira da CostaDepartamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Marcelo MachadoDebasé Audiovisual, Sao Paulo, Brazil.
Evelyn da Silva BitencourtFaculdade de Arquitetura e Urbanismo FAU, Universidade de Sao Paulo, Sao Paulo, Brazil.
Monica Souza Dos SantosDepartamento de Psiquiatria, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil.
Jamie MurdochDepartment of Population Health Sciences, King's College London, London, UK.
Pepijn van de VenHealth Research Institute, University of Limerick, Limerick, Ireland.
Nadine SewardHealth Service and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
William HollingworthHealth Economics Bristol, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Tim J PetersPopulation Health Sciences, Bristol Medical School, and Bristol Dental School, University of Bristol, Bristol, UK.
Ricardo ArayaHealth Service and Population Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.ORCID http://orcid.org/0000-0002-0420-5148
Universidade de São Paulo · BRKing's College London · GBHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRUniversity of Bristol · GBUniversity Of Bristol Dental Hospital · GBUniversity of Limerick · IE

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2017/50094-2Medical Research Council MR/R006229/1MRF MR/R006229/1
6 · The paper itself

Abstract

backgroundDepression in older adults is a challenge for health systems in most low- and middle-income countries (LMICs). Digital strategies for the management of this condition have been emerging worldwide, but the effectiveness of most of them is still unclear, especially among older adults. Thus, we aim to assess the effectiveness and cost-effectiveness of a digital psychosocial intervention to treat depression among older adults living in socioeconomically deprived areas in Guarulhos, Brazil.

methodsWe will conduct a two-arm individually randomised controlled trial with 1:1 allocation ratio. Five hundred older adults aged 60 years or over with depressive symptomatology (9-item Patient Health Questionnaire score, PHQ-9 ≥ 10) and registered with one of the primary care clinics will be recruited to participate in this study. A 6-week digital psychosocial programme, named Viva Vida, will be delivered via WhatsApp to participants allocated to the intervention arm. The Viva Vida will send psychoeducational and behavioural activation audio and visual messages 4 days a week for 6 weeks. The control arm will only receive a single message with general information about depression. The primary outcome will be the proportion of depression recovery (PHQ-9 < 10) assessed at 3 months. The cost-effectiveness of the intervention will be assessed at 5 months. A detailed process evaluation will be used to explore context and important implementation outcomes. DISCUSSION: This programme was based on the PROACTIVE intervention and designed to be delivered without face-to-face contact. If effective, it could be a simple treatment option, appropriate not only when social distancing is required, but it could also be included as a regular public health programme to initiate depression treatment, particularly in LMICs where resources allocated to mental health are scarce.

trial registrationRegistro Brasileiro de Ensaios Clínicos (ReBEC), RBR-4c94dtn. Registered on 22 October 2021 (submitted on 03 August 2021).

Indexed as

DepressionPsychosocial InterventionAgedBrazilHumansMental HealthRandomized Controlled Trials as TopicTreatment OutcomeBehavioural activationBrazilDepressionDigital interventionLow- and middle-income countriesProcess evaluationPsychoeducationPsychosocial interventionRandomised controlled trial

Identifiers

PMID36071463
PMCPMC9449935
OpenAlexW4294992376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.